Navigation Links
Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
Date:12/14/2010

atters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX2931 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Ill. , Dec. 19, 2014   Hospira, ... leading provider of injectable drugs and infusion technologies, today ... Morgan 33rd Annual Healthcare Conference on Wednesday, Jan. 14, ... presentation is scheduled to begin at 10:30 a.m. Pacific ... available to all interested parties through a live audiocast ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
(Date:12/19/2014)... LOS ALTOS, Calif. , Dec. 18, 2014 ... of a new generation of equipment for the ... today the release of the new Luminary™ Profiler, ... highly accurate light-based measurement in a cost-effective, portable ... to meet the specific needs of the cannabis ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... October 12, 2011 Leading health ... titles freely available through UN developing world research access ... scientific, technical and medical information products and services, today ... books to Research4Life , a public-private partnership working ...
... Mass., Oct. 11, 2011 Boston Scientific Corporation (NYSE: ... results for the third quarter ended September 30, 2011 on ... call will be hosted by Hank Kucheman, who becomes Boston ... Executive Vice President and Chief Financial Officer. A ...
Cached Medicine Technology:Elsevier Offers 950 New Health Titles to Research4Life 2Elsevier Offers 950 New Health Titles to Research4Life 3Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 2
(Date:12/21/2014)... 21, 2014 SCI explores ... issues and systemic barriers for disabled athletes with ... Scheidies has a condition called juvenile macular degeneration, where ... how he adapted his athletic ambitions to his vision ... in triathlon to pioneer the way for other blind ...
(Date:12/21/2014)... Concept Plus, LLC. a SDB and ... Fairfax, VA., today announced it has been recognized by ... which ranks the fastest growing government contracting small businesses by ... , This is the first year that Concept Plus, LLC., ... with a 95.92% compound annual growth rate. “For Concept Plus ...
(Date:12/20/2014)... NY (PRWEB) December 20, 2014 An ... healthcare sector have benefited the Massage Services ... discretionary characteristics of industry products, the anticipated 1.0% annualized ... period has provided consumers with the means to afford ... have received a massage in a given year has ...
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress wholesaler ... Online for 2015. Great discounts are now offered ... consumers can get a discount, up to 80% off, ... before January 30, 2015. , VogueQueen.com has recently released ... prom dress promotion. Many customers worldwide like VogueQueen’s special ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The aftermath of ... quite a stir, not only in Hollywood, but worldwide. ... 18th , the ripples of that attack are starting a ... jobs at risk. But they are not the only ... could be in for some embarrassing times ahead, agents and ...
Breaking Medicine News(10 mins):Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5
... Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., ... Center is the recipient of the 2011 American Society ... for Excellence in Tobacco Research. "I,m humbled by ... dedication, innovative programs and collaboration with health care professionals, ...
... , WEDNESDAY, Dec. 8 (HealthDay News) -- Omega-3 fatty acids ... of fatty acid called DHA is used in the right ... study suggests. The researchers analyzed the results of some ... -- commonly found in oily fish or in fish oil ...
... health researchers at Indiana University found that women who ... satisfaction and pleasure. The study, involving 2,453 women, ... the widespread commercial availability of lubricant and the gaps ... contributing to other health issues. "In spite of ...
... large European study suggest that poorly educated people are more ... than the better educated, even after differences in lifestyle have ... (Thursday 9 December) in the European Heart Journal ... as 31 years (range 0-31 years, average follow-up was 21 ...
... survive an episode of mechanical ventilation during a hospitalization ... leaving the hospital than those who survive hospitalization without ... Pittsburgh. These results were borne out even though the ... in both groups. The study was published online ...
... recommended to decrease the incidence of urinary tract infections, ... trials. However, a new study published in the ... and now available online ( http://cid.oxfordjournals.org/content/52/1/23.full ), suggests otherwise. ... urinary tract infection were assigned to drink eight ounces ...
Cached Medicine News:Health News:Cancer prevention expert honored for innovative tobacco research 2Health News:Certain Formulations of Omega-3s Might Help With Depression 2Health News:Certain Formulations of Omega-3s Might Help With Depression 3Health News:Study examines effect of water-based and silicon-based lubricant 2Health News:Study examines effect of water-based and silicon-based lubricant 3Health News:Lower levels of education are associated with increased risks of heart failure 2Health News:Lower levels of education are associated with increased risks of heart failure 3Health News:Lower levels of education are associated with increased risks of heart failure 4Health News:Older survivors of mechanical ventilation can expect significant disability 2Health News:Older survivors of mechanical ventilation can expect significant disability 3
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
... of comminution, aspiration and irrigation ... ultra-sonic energy. Allows for preservative ... particular, parenchymatous organs, offering the ... non-traumatic preparation with a low ...
Medicine Products: